Royalty Pharma PLC at RBC Capital Markets Global Healthcare Conference Transcript
(audio in progress) company, which is Royalty Pharma. And it's my pleasure to have with me today, Marshall Urist, who is the EVP, Executive Vice President, and Head of Research and Investments at the company.
Let me start with an interesting anecdote, because I know I have big shoes to fill with respect to Greg leaving, and he was the one who interviewed you last year, but I covered my first royalty company actually in the late 1990s before it was taken over. And it's interesting because I cover a couple of them right now, but you guys have done such an incredible job over the last decade and even more, but -- while you've been public.
Questions & Answers
And with that, how we'd like to start this conversation is I want you to share your perspective on outlook for royalty financing right now in the context of the current macro environment. But also, there's been a few things that have been going on in the market, the way I understand it, in the alt and private credit groups that have acquired some of these
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
